Philipp Heinz

In regulated diagnostics, the hard question isn't "what's the strategy?" It's whether it survives a real lab, a real procurement team, and real regulation. That's the gap I close.

12 years at Roche Diagnostics, where I built and led the portfolio-integration function and the methodology Roche used to turn complex product, software, and service portfolios into integrated customer solutions.

I'm not a slide-deck strategist. AI can draft a polished plan in minutes; what it can't tell you is where that plan quietly fails inside a clinical lab. I can.

I help medtech, diagnostics, and regulated-tech companies (founders, product leaders, investors) with product and portfolio strategy, solution design, go-to-market, regulatory alignment (IVDR, MDR, AI Act, Machinery Regulation), and the deployment of robotics and AI in regulated environments. DACH and global, German and English.

Whether it's a product concept, a go-to-market plan, a pitch deck, or an AI-drafted strategy, I'll give you an honest read on what's working, where the commercial risks lie, and what to prioritise next.